ASCO-ESMO cooperation boosted ES by shimeiyan



tion between preclinical research and phase I trials:
Phase II trials will probably become a standard part of
this operation only later. From the beginning, the cen-
tral office of SENDO will cooperate closely with NDDO,
CRC, EMEA, FDA and NCI. The NCI, especially has
contributed substantially to the launching of this
   The main factor which led to the creation of SENDO
is that the huge potential of this oncologic stronghold
in Northern Italy/Southern Switzerland was not being
sufficiently exploited in the very important field of new
drugs development This aspect of oncology is less
well developed in the remaining parts of Southern                                             Prof. Jim Armitage, current
Europe, and SENDO is projected to promote such                                                ASCO President and driv-
research in those countries.                                                                  ing force behind trie estab-
   One of the major assets of the new structure is the                                        lishment of official links with
fact that these institutions together can count on an
impressive array of preclinical support, from molecular
biology to screening facilities.                             for full-time oncologists not residing in Europe). How-
   The central office of SENDO will be headed by             ever, ASCO members will no longer be required to go
Silvia Marsoni, MD, who has had a great deal of ex-          through the lengthy bureaucratic procedure for be-
perience in this field, since completion of her training     coming an ESMO member, but will only need to prove
at the NCI more than a decade ago. The preclinical           that they are ASCO members and demonstrate "where
unit will be headed by Raffaella Giavazzi, PhD and the       they live and what they do".
clinical unit will be under the leadership of Cristiana         Furthermore, ASCO will look into how ESMO con-
Sessa, MD, Bellinzona                                        gresses can obtain CME-credit points which would
    Observers have noted that SENDO could be seen            make it much easier for US oncologists to participate
as a competitor of the NDDO, but this may ultimately         in ESMO congresses. In the near future, the two soci-
not be the case. In fact, the three European strong-         eties will discuss the possibility of jointly supporting
holds (CRC, NDDO and SENDO) could soon represent             major projects in which both would play significant
a critical mass which in this field could outweigh even      rolea This applies mainly to activities in countries with
the American groups.                                         limited resources, for which projects have been sub-
                                                             mitted to both societies (Ann Oncol 1996; 7(8): 763-4).

ASCO-ESMO cooperation boosted                                ESMO Vienna

During the ESMO Congress in Vienna, high-ranking             Almost 6,000 oncologists convened in Vienna for the
delegations from the ASCO and the ESMO met to for-           21st ESMO Congress, the second to have been direct-
malize their mutual willingness to increase coopera-         ly organized by the ESMO Secretariat in Lugano. This
tion between their respective organizations.                 time around none of the problems which plagued the
   A number of long-range decisions were taken at the        preceding event in Lisbon in 1994 (Ann Oncol 1995;
meeting. First, a joint ASCO-ESMO Standing Commit-           6(2): 99-100) were encountered, also because the
tee was created which will meet twice a year during          cooperation between the Lugano office and the local
either the ASCO or the ESMO/ECCO meetings. The               organiser, Prof. H. Ludwig, was invariably positive and
task of this committee will be to review ongoing collabo-    constructive.
rations and to look for new possibilities for cooperation.
Beginning already in 1997 there will be reciprocal repre-
sentation in the educational committees of the two so-
cieties, while the Scientific Program Committee (which
prepares succeeding Congresses) will also include
members and experts from the other society.
   Reciprocity of membership was again discussed.
While ASCO has already decided to accept new Euro-
pean members contingent upon demonstration of
their ESMO membership, it is somewhat more difficult
for ESMO, which has different member categories                                                Prof. H. Ludwig, local
(e.g., associated membership for physicians who are                                            organizer of the Vienna
not full-time oncologists, corresponding membership                                            meeting

To top